Charles A Rowland Jr's Net Worth
Charles A Rowland Jr's net worth is estimated to be at least $3,753,942.47 as of 05/07/2024. CoreStreet's estimation of Charles A Rowland Jr's net worth is based on their sale of stock and current holding of stock.
Charles A Rowland Jr is Director at Viking Therapeutics Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 40,000 units of VKTX stock on 05/16/2023. Their biggest sale was on 12/17/2020 when they sold 10,909 units of Blueprint Medicines Corp stock for $1,285,298.38. They typically trade 1 times per year.
Total value of insider buys:
- $342,717.07
Total value of insider sells:
- $3,411,225.40
Most recent insider trade:
- May 16, 2023
Charles A Rowland Jr's Insider Trading History
| Viking Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 16, 2023 | Director | 40,000 | $25.00 | Sell | $1,000,000.00 |
| Generation Bio Co | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 19, 2022 | Director | 15,750 | $5.26 | Buy | $82,845.00 |
Sept. 15, 2022 | Director | 17,147 | $5.41 | Buy | $92,765.27 |
Sept. 13, 2022 | Director | 18,784 | $5.20 | Buy | $97,676.80 |
| Nabriva Therapeutics AG | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 1, 2022 | Director | 8,496 | $0.17 | Sell | $1,444.32 |
Dec. 24, 2018 | Director | 53,000 | $1.31 | Buy | $69,430.00 |
| Blueprint Medicines Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 17, 2020 | Director | 10,909 | $117.82 | Sell | $1,285,298.38 |
June 20, 2019 | Director | 11,818 | $95.15 | Sell | $1,124,482.70 |